NET PROFIT (x1000 NOK)
EMPLOYEES
Enza Biotech AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-9,020
|
-8,177
|
-7,609 |
| EBITDA |
-8,401
|
-7,595
|
-7,048 |
| Total assets |
5,606
|
5,205
|
5,690 |
| Current assets |
2,334
|
1,714
|
1,659 |
| Current liabilities |
1,795
|
981
|
902 |
| Equity capital |
3,811
|
4,224
|
4,788 |
| - share capital |
280
|
261
|
269 |
| Employees (average) |
5
|
5
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
68.0%
|
81.2%
|
84.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-160.9%
|
-157.1%
|
-133.7% |
| Current ratio |
130.0%
|
174.7%
|
183.9% |
| Return on equity (ROE) |
-236.7%
|
-193.6%
|
-158.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.